Login

"Tech Wing will be led by new CEO Hareesh Achi, transitioning from Evan Gappelberg, while Cadiz Inc. is headed by CEO Susan Kennedy."|Jae Shim is the CEO of TechWing. 00:10:00

Share On Facebook Share On Twitter

Jae Shim is the CEO of TechWing.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Balancing Real Estate and Energy: Strategic Growth with Opportunity Fund | Insights from the Opportunity Fund Team
00:10:00
Longview: A Journey of Trust and Partnership in Financial Planning | Jessica Smith, President, Longview Financial Advisors, Inc..
00:10:00
Exploring Free Speech and Campus Controversies|Lindsay Shepherd,Professor,Simon Fraser University in Burnaby
00:10:00
Evolving Retail Real Estate: Insights from a Veteran Operator | Eric Sherman, Head of National Operations , First Capital REIT.
00:10:00
Leading the Charge: First Investors and Continued Commitment|Calvin Chin,Managing Partner,The E14 Fund
00:10:00
Challenges and Disparities in New Zealand's Aged Care System Prompt Concerns Over Future Accessibility and Quality of Care|Jeremy Nicoll, CEO, Arvida Group Ltd.
00:10:00
Navigating Yield Sustainability in Australian Healthcare Property Investments| David Burgess, Co-Head , Elanor Commercial Property Fund.
00:10:00
Unveiling the Motivations behind Evolis' Intended Sale to HID Group | Emmanuel Picot, CEO of Evolis sa
00:10:00
Kobo Resources: Advancing Gold Exploration in Cote d'Ivoire
00:10:00
Hendrik Bischof from HUBER+SUHNER discusses his role in Group Strategy and M&A and his experiences working at the company.
00:10:00
Differentiating to Win in the New Environment|Marell Evans,Founder and Managing Director,Exceptional Capital
00:10:00
Key Considerations When Choosing a Financial Advisor

© 2017 - Neuhu+